NxThera Completes $12.6 Million in Series B Financing for Treating BPH
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.
bph
Urologix and Uroplasty: Treatments for Common Urinary Disorders
Voiding the bladder is one of the most basic human functions, so mundane that we pay it little mind most of the time.